Document
... from C4/H5N1 and the remaining six genes from F, which is not pathogenic and replicate for mice and low pathogenic for chickens. the C4/F reassortant showed good growth characteristic with the HA titer as high as 1:2048. ...
... from C4/H5N1 and the remaining six genes from F, which is not pathogenic and replicate for mice and low pathogenic for chickens. the C4/F reassortant showed good growth characteristic with the HA titer as high as 1:2048. ...
Effective use of Vaccinations on Cow Calf operations to reduce the
... gaps in vaccination programs is not following up the initial vaccination with a booster vaccination at the recommended time (Hjerpe 1996). When vaccinating replacement heifers, it is important to make sure that the heifer receives two doses of modified live virus vaccines previous to being bred ...
... gaps in vaccination programs is not following up the initial vaccination with a booster vaccination at the recommended time (Hjerpe 1996). When vaccinating replacement heifers, it is important to make sure that the heifer receives two doses of modified live virus vaccines previous to being bred ...
403.3E1 Page 1 of 4 HEPATITIS B VACCINE INFORMATION AND
... The HBV vaccine is produced from yeast cells. It has been extensively tested for safety and effectiveness in large scale clinical trials. Approximately 90 percent of healthy people who receive two doses of the vaccine and a third dose as a booster achieve high levels of surface antibody (anti-HBs) a ...
... The HBV vaccine is produced from yeast cells. It has been extensively tested for safety and effectiveness in large scale clinical trials. Approximately 90 percent of healthy people who receive two doses of the vaccine and a third dose as a booster achieve high levels of surface antibody (anti-HBs) a ...
tackling emerging and re-emerging infectious diseases
... § Vaccine for other flaviviruses have been developed and used for over 70 years § Active development programs for Dengue and West Nile vaccines have been ongoing for over 30 years, exploring a variety of vaccine platforms to develop vaccines for these flaviviruses § Experiences gained and vaccine ...
... § Vaccine for other flaviviruses have been developed and used for over 70 years § Active development programs for Dengue and West Nile vaccines have been ongoing for over 30 years, exploring a variety of vaccine platforms to develop vaccines for these flaviviruses § Experiences gained and vaccine ...
Bioweapons - Texas A&M University–Central Texas
... • Hypothesis: Ishii and Kitano deliberately avoided use of controls (i.e. comparison to plague deaths in non-BW areas) in order to produce results (think US BMD tests or manufacturers’ tests of effectiveness for parallels) • Hypothesis suggests deaths were >10,000 (killed directly) but <250,000 (bec ...
... • Hypothesis: Ishii and Kitano deliberately avoided use of controls (i.e. comparison to plague deaths in non-BW areas) in order to produce results (think US BMD tests or manufacturers’ tests of effectiveness for parallels) • Hypothesis suggests deaths were >10,000 (killed directly) but <250,000 (bec ...
this presentation (Pt. 2) - cacuss/aseucc 2007
... immunity levels). • Risk of: – Exposure to infected patients (differs in various health-care ...
... immunity levels). • Risk of: – Exposure to infected patients (differs in various health-care ...
Tdap - Health and Community Services
... Tdap vaccines are indicated for active immunization against tetanus, diphtheria and pertussis. Adolescents age 14 -16 years receive Tdap vaccine in school as part of the school grade 9 immunization program. Adults are considered to be a significant source of transmission of pertussis to infants and ...
... Tdap vaccines are indicated for active immunization against tetanus, diphtheria and pertussis. Adolescents age 14 -16 years receive Tdap vaccine in school as part of the school grade 9 immunization program. Adults are considered to be a significant source of transmission of pertussis to infants and ...
Outbreak of Varicella in a School in Catania (Sicily)
... Introduction: Varicella is a highly contagious infectious disease, due to varicella-zoster virus which spreads mainly via aerosolized droplet nuclei or direct contact with fluid from a varicella rash. The period of communicability extends from 1 to 2 days before the onset of the rash through the fir ...
... Introduction: Varicella is a highly contagious infectious disease, due to varicella-zoster virus which spreads mainly via aerosolized droplet nuclei or direct contact with fluid from a varicella rash. The period of communicability extends from 1 to 2 days before the onset of the rash through the fir ...
Vaccines - British Society for Immunology
... remained consistently below 100 but had risen to 2,016 cases in 2012.5 Unfortunately, there have been several needless deaths during these outbreaks. Safety of vaccination As with all medical interventions, vaccination is not entirely risk free. Any vaccine can have side effects, though these are la ...
... remained consistently below 100 but had risen to 2,016 cases in 2012.5 Unfortunately, there have been several needless deaths during these outbreaks. Safety of vaccination As with all medical interventions, vaccination is not entirely risk free. Any vaccine can have side effects, though these are la ...
a mathematical simulation of the inflammatory response to anthrax
... administration. Antibiotics may work for cutaneous and gastrointestinal anthrax. However, it has been widely accepted that, by the time the symptoms of inhalational anthrax are present, it is often too late for antibiotic therapy to be effective (5, 31, 32). Several vaccines have been developed to p ...
... administration. Antibiotics may work for cutaneous and gastrointestinal anthrax. However, it has been widely accepted that, by the time the symptoms of inhalational anthrax are present, it is often too late for antibiotic therapy to be effective (5, 31, 32). Several vaccines have been developed to p ...
Partnership opportunities with Sano Pasteur
... Sanofi Pasteur is interested in potential partnering opportunities in the field of active and passive human immunization, as well as technologies supporting product development and industrial performance, including: Vaccines, monoclonal antibodies and supporting technologies for prevention and treat ...
... Sanofi Pasteur is interested in potential partnering opportunities in the field of active and passive human immunization, as well as technologies supporting product development and industrial performance, including: Vaccines, monoclonal antibodies and supporting technologies for prevention and treat ...
Ebola vaccine 2014: remained problems to be answer
... Finding for pandemic vaccine has to be rapidly done and this is usually question for the effectiveness and safety, similar to the situation of the previous 2009 Swine flu outbreak [4]. First, the basic search for immunological epitope and further peptide candidate development can be done with help o ...
... Finding for pandemic vaccine has to be rapidly done and this is usually question for the effectiveness and safety, similar to the situation of the previous 2009 Swine flu outbreak [4]. First, the basic search for immunological epitope and further peptide candidate development can be done with help o ...
Заголовок слайда отсутствует
... infectious from 1 week before symptoms begin until 5 days after the rash appears. Therefore, affected children should stay away from school and not mix with others for 5 days after the rash starts. Most women are immune due to previous immunization and will not develop rubella. No further action is ...
... infectious from 1 week before symptoms begin until 5 days after the rash appears. Therefore, affected children should stay away from school and not mix with others for 5 days after the rash starts. Most women are immune due to previous immunization and will not develop rubella. No further action is ...
summary of product characteristics
... Indications for use, specifying the target species Active immunisation of cats to reduce mortality and clinical signs of disease caused by feline enteritis (panleucopaenia) virus, to reduce clinical signs of disease caused by feline rhinotracheitis virus and to prevent clinical signs of disease and ...
... Indications for use, specifying the target species Active immunisation of cats to reduce mortality and clinical signs of disease caused by feline enteritis (panleucopaenia) virus, to reduce clinical signs of disease caused by feline rhinotracheitis virus and to prevent clinical signs of disease and ...
Targeting the tick - Horizon Magazine
... people who opt to be vaccinated is low in most European countries. The researchers think that if a single vaccine could protect against a range of diseases at once, uptake rates might increase. Ticks need to feed on blood in order to reproduce. A vaccine which disrupted tick feeding or the reproduct ...
... people who opt to be vaccinated is low in most European countries. The researchers think that if a single vaccine could protect against a range of diseases at once, uptake rates might increase. Ticks need to feed on blood in order to reproduce. A vaccine which disrupted tick feeding or the reproduct ...
Biological Weapons
... Tularemia, also known as rabbit fever, is a disease that caused by a bacterium, Francisella tularemsis. This disease is named as rabbit is the species most often involved in disease outbreaks. The infection can be by inoculation of the skin or mucous membranes with blood or tissue while handling, dr ...
... Tularemia, also known as rabbit fever, is a disease that caused by a bacterium, Francisella tularemsis. This disease is named as rabbit is the species most often involved in disease outbreaks. The infection can be by inoculation of the skin or mucous membranes with blood or tissue while handling, dr ...
Notebook
... Explain the principle of vaccination Different vaccines are introduced into the body by different routes: into the muscle; into the skin; into the lungs; etc. After the first exposure to a vaccine (or any antigen), no antibodies are present in the blood for several days. Then there is a slow rise o ...
... Explain the principle of vaccination Different vaccines are introduced into the body by different routes: into the muscle; into the skin; into the lungs; etc. After the first exposure to a vaccine (or any antigen), no antibodies are present in the blood for several days. Then there is a slow rise o ...
Here - Canadian Bison Association
... No trials have been done in bison to prove immune stimulation or response on a cellular of humoral level. Dose and/or frequency of re-administration (same as cattle?). What if we were able to find an immune response, is it protective? ...
... No trials have been done in bison to prove immune stimulation or response on a cellular of humoral level. Dose and/or frequency of re-administration (same as cattle?). What if we were able to find an immune response, is it protective? ...
Influenza Vaccine Trivalent Inactivated Adjuvanted FLUAD
... swelling of injected limb lasting more than one week, allergic reactions leading to shock, angioedema, vasculitis, thrombocytopenia, ...
... swelling of injected limb lasting more than one week, allergic reactions leading to shock, angioedema, vasculitis, thrombocytopenia, ...
IMMUNOTHERAPY:
... little effort on behalf of the patients and has shown to produce few to no side effects. While an addict should look to every possible source to find an appropriate therapy tailored to his or her needs, one may find that looking inward and using the body’s own defenses may be what is required to hel ...
... little effort on behalf of the patients and has shown to produce few to no side effects. While an addict should look to every possible source to find an appropriate therapy tailored to his or her needs, one may find that looking inward and using the body’s own defenses may be what is required to hel ...
Lecture 4
... the antigen wanes. The result of this immunologic stimulation is the production of a reserve pool of antibodies that is capable of overcoming the virulent variant of the same disease agent in the vaccine. However, antibodies naturally decline with time and therefore it is necessary to restimulate (b ...
... the antigen wanes. The result of this immunologic stimulation is the production of a reserve pool of antibodies that is capable of overcoming the virulent variant of the same disease agent in the vaccine. However, antibodies naturally decline with time and therefore it is necessary to restimulate (b ...
Biological warfare: the facts - Hong Kong College of Emergency
... first medication approved by the FDA for prophylaxis after exposure to a biological weapon (anthrax). Should an attack be confirmed as anthrax, antibiotics should be continued for at least 4 weeks in all those exposed, and until all those exposed have received three doses of the vaccine. Those who h ...
... first medication approved by the FDA for prophylaxis after exposure to a biological weapon (anthrax). Should an attack be confirmed as anthrax, antibiotics should be continued for at least 4 weeks in all those exposed, and until all those exposed have received three doses of the vaccine. Those who h ...
Vaccination
... Annual morbidity before the vaccine became available compared to morbidity in 1998 ...
... Annual morbidity before the vaccine became available compared to morbidity in 1998 ...